David Garcia-Azorin
Overview
Explore the profile of David Garcia-Azorin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
128
Citations
1333
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sierra-Mencia A, Recio-Garcia A, Garcia-Azorin D, de la Torre A, Gonzalez I, Guerrero-Peral A
J Headache Pain
. 2025 Feb;
26(1):34.
PMID: 39953381
Background: The relationship between physical activity (PA) and migraine is insufficiently understood. Studies have not analysed levels of PA or Time Sitting (TS) during preventive treatment, nor the role these...
2.
Petrusic I, Chiang C, Garcia-Azorin D, Ha W, Ornello R, Pellesi L, et al.
J Headache Pain
. 2025 Jan;
26(1):2.
PMID: 39748331
Part 2 explores the transformative potential of artificial intelligence (AI) in addressing the complexities of headache disorders through innovative approaches, including digital twin models, wearable healthcare technologies and biosensors, and...
3.
Tana C, Bernardinello N, Raffaelli B, Garcia-Azorin D, Waliszewska-Prosol M, Tana M, et al.
Ann Med
. 2024 Dec;
57(1):2445191.
PMID: 39723989
Background: There has been significant progress in understanding neurosarcoidosis (NS) as a distinct disorder, which encompasses a heterogeneous group of clinical and radiological alterations which can affect patients with systemic...
4.
Gollion C, Garcia-Azorin D
Cephalalgia
. 2024 Dec;
44(12):3331024241300883.
PMID: 39655471
No abstract available.
5.
Romozzi M, Lokhandwala A, Vollono C, Vigani G, Burgalassi A, Garcia-Azorin D, et al.
Cephalalgia
. 2024 Dec;
44(12):3331024241262751.
PMID: 39654467
Background: The present study aimed to determine whether machine-learning (ML)-based models can predict 3-, 6, and 12-month responses to the monoclonal antibodies (mAbs) against the calcitonin gene-related peptide (CGRP) or...
6.
Pozo-Rosich P, Garcia-Azorin D, Diaz-Cerezo S, Fernandez-Montoya J, de Paz H, Nunez M
Front Neurol
. 2024 Dec;
15:1502475.
PMID: 39639987
Introduction: In the context of migraine preventive therapy, new therapeutic modalities such as monoclonal antibodies targeting the calcitonin gene-related peptide receptor (CGRP) or ligand offer potential advantages over traditional preventive...
7.
Pellesi L, Garcia-Azorin D, Rubio-Beltran E, Ha W, Messina R, Ornello R, et al.
J Headache Pain
. 2024 Dec;
25(1):214.
PMID: 39639191
Combination treatments for migraine prophylaxis present a promising approach to addressing the diverse and complex mechanisms underlying migraine. This review explores the potential of combining oral conventional prophylactics, onabotulinumtoxin A,...
8.
Puledda F, de Boer I, Messina R, Garcia-Azorin D, Portes Souza M, Al-Karagholi M, et al.
Cephalalgia
. 2024 Nov;
44(11):3331024241297688.
PMID: 39552307
Background: In this study, we aimed to evaluate the differing global access to acute and preventive medications for migraine and tension-type headache. Methods: A custom-built questionnaire created by members of...
9.
Raggi A, Leonardi M, Arruda M, Caponnetto V, Castaldo M, Coppola G, et al.
J Headache Pain
. 2024 Nov;
25(1):189.
PMID: 39482575
Background And Aim: Migraine is a common disabling conditions which, globally, affects 15.2% of the population. It is the second cause of health loss in terms of years lived with...
10.
Leonardi M, Colonna I, Garcia-Azorin D, Bereczki D, Bodini B, Bregman N, et al.
Eur J Neurol
. 2024 Oct;
31(12):e16516.
PMID: 39429124
Background And Purpose: The European Academy of Neurology (EAN) has adhered to the global plan for reducing the burden of neurological disorders and promoting brain health launched by the World...